Skip to main content
C

ChengDa Pharmaceuticals Co.,Ltd. — Investor Relations & Filings

Ticker · 301201 Shenzhen Stock Exchange Manufacturing
Filings indexed 449 across all filing types
Latest filing 2025-10-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301201

About ChengDa Pharmaceuticals Co.,Ltd.

https://www.chengdapharm.com

ChengDa Pharmaceuticals Co., Ltd. specializes in the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company maintains a diverse product portfolio with a significant focus on the L-carnitine series, including levocarnitine and its derivatives, serving as a major global supplier. Its therapeutic areas of expertise encompass cardiovascular health, metabolic disorders, and anti-infective treatments. ChengDa Pharmaceuticals operates advanced production facilities that adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications from regulatory bodies such as the FDA and EDQM. The organization emphasizes technological innovation and process optimization to provide high-purity chemical components for the global market, supporting both generic and proprietary drug development.

Recent filings

Filing Released Lang Actions
募集资金管理制度
Regulatory Filings
2025-10-27 Chinese
内部审计制度
Regulatory Filings
2025-10-27 Chinese
总经理工作细则
Regulatory Filings
2025-10-27 Chinese
信息披露管理制度
Regulatory Filings
2025-10-27 Chinese
独立董事候选人声明与承诺(周钧明)
Regulatory Filings
2025-10-27 Chinese
第五届董事会提名委员会关于独立董事候选人任职资格的审查意见
Regulatory Filings
2025-10-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.